Skip to content

Clinical trials

Phase 2 Diabetic Nephropathies trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Phase 2 Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20121
20131
20181
20191
20202
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
AstraZeneca1
Bayer1
Boehringer Ingelheim1
CSL Behring1
Dimerix Bioscience Pty Ltd1
Eli Lilly and Company1
Gilead Sciences1
Novartis Pharmaceuticals1
Synvista Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies12
Diabetes Mellitus, Type 23
Renal Insufficiency, Chronic3
Diabetes Mellitus, Type 12
Glomerulonephritis, IGA2
Albuminuria1
Glomerulosclerosis, Focal Segmental1
Kidney Failure, Chronic1
Nephritis, Hereditary1
Nephrosis, Lipoid1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.